Sort
11,323 grants matching “glioblastoma”
Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.
$253,380Adam M Sonabend · University Of California, San Francisco · U19 · FY2021 · CA
Project 2: Overcoming GBM RT-resistance
$253,257Daniel R Wahl · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Modulation of Glioma Growth and Invasion by HCMV Glycoprotein B
$253,050Liliana Soroceanu · California Pacific Med Ctr Res Institute · R21 · FY2009 · NS
High-Grade Astrocytoma-specific Molecular Targeting
$252,947Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2010 · CA
Dissecting Glioma Genesis through a Glial-Specific Mouse Model
$252,836Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Dissecting Glioma Genesis through a Glial-Specific Mouse Model
$252,836Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Establishment of a Human Grade IV Glioma Stem Cell Line Bank
$252,806Brent Reynolds · University Of Florida · R24 · FY2016 · NS
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
$252,801Anita Borton Hjelmeland · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
$252,801Anita Borton Hjelmeland · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
Novel Reporters and Delivery Vehicles
$252,731Xandra Owens Breakefield · Massachusetts General Hospital · P50 · FY2009 · CA
Novel oncolytic virotherapy for brain tumors
$252,708Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2018 · NS
Clinical Trial Operations Core
$252,623Annick Desjardins · Duke University · P50 · FY2020 · CA
Core 3: Mouse GBM models and Imaging Core
$252,569E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
Targeting MELK-mediated EZH2 signaling in glioma stem cells
$252,565Ichiro Nakano · Ohio State University · R01 · FY2014 · NS
MDA-7/IL-24: Therapy of Malignant Glioma
$252,519Paul Dent · Columbia University Health Sciences · P01 · FY2006 · CA
Neural Progenitor Genes and Brain Tumors
$252,515Harley I Kornblum · University Of California Los Angeles · R01 · FY2006 · NS
MR Guided Focused Ultrasound Controlled Stem Cell Therapy for Brain Tumor
$252,485King C. Li · University Of Illinois At Urbana-Champaign · R01 · FY2016 · CA
Establishment of a Human Grade IV Glioma Stem Cell Line Bank
$252,477Brent Reynolds · University Of Florida · R24 · FY2017 · NS
'Arresting' bone marrow T cell sequestration in patients with GBM
$252,437Peter Fecci · Duke University · P50 · FY2023 · CA
SPORE: Targeted Therapies for Glioma - Diversity Supplement
$252,388Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2022 · CA
Neoantigen immunotherapy in brain tumors using anti-CD27 to deplete regulatory T cells selectively
$252,322John H Sampson · Duke University · P50 · FY2020 · CA
Pharmacologic and Genomic Imaging Core
$252,316Mario Luca Suva · Brigham And Women'S Hospital · U19 · FY2025 · CA
Brain Tumor Imaging and Therapy Using Magnetic Nanoparticles
$252,299Wenbin Lin · Univ Of North Carolina Chapel Hill · U54 · FY2007 · CA
Phase 2 Study of TH-302 for the Treatment of Glioblastoma
$252,191Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2020 · FD
Core 1: The Single Cell Profiling Core Facility
$252,154Rong Fan · Dana-Farber Cancer Inst · U54 · FY2016 · CA